Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
Related Posts
Dodgers headed to the World Series after Game 6 victory against the Mets
The Dodgers are headed to the World Series after defeating the Mets10-5 in Game 6 of the National League Championship…
Delphi, Ind., murder trial continues with details of search for missing girls
Richard Allen stands accused of killing the girls, Abby Williams and Libby German, in 2017.
Tips for Thanksgiving and Black Friday shoppers
CBS News’ Nancy Chen has some information you should know if you’re hitting the stores or clicking away online as…